Thursday, November 20, 2008 - 5:24PM EST

Clinical Trials

81. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

Author
Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH; Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH; Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH;
Institution
Vanderbilt University, Nashville, TN, USA. sandler@vanderbilt.edu
Journal
N Engl J Med. 2006 Dec 14;355(24):2542-50.
Abstract URL
Click here to view abstract

82. Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer.

Author
Park SH; Choi SJ; Kyung SY; An CH; Lee SP; Park JW; Jeong SH; Cho EK; Shin DB; Hoon Lee J; Park SH; Choi SJ; Kyung SY; An CH; Lee SP; Park JW; Jeong SH; Cho EK; Shin DB; Hoon Lee J;
Institution
Division of Oncology and Pulmonology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Journal
Cancer. 2007 Feb 15;109(4):732-40.
Abstract URL
Click here to view abstract

83. Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer.

Author
Yokomise H; Gotoh M; Okamoto T; Yamamoto Y; Ishikawa S; Nakashima T; Masuya D; Liu D; Huang CL; Yokomise H; Gotoh M; Okamoto T; Yamamoto Y; Ishikawa S; Nakashima T; Masuya D; Liu D; Huang CL;
Institution
Second Department of Surgery, Faculty of Medicine, Kagawa University, Miki-cho, Japan. yokomise@kms.ac.jp
Journal
J Thorac Cardiovasc Surg. 2007 May;133(5):1179-85.
Abstract URL
Click here to view abstract

84. Chemotherapy resistance and oncogene expression in non-small cell lung cancer.

Author
d'Amato TA; Landreneau RJ; Ricketts W; Huang W; Parker R; Mechetner E; Yu IR; Luketich JD; d'Amato TA; Landreneau RJ; Ricketts W; Huang W; Parker R; Mechetner E; Yu IR; Luketich JD;
Institution
Jefferson Medical College, Division of Cardiothoracic Surgery, Thomas Jefferson University, Philadelphia, Pa 19107, USA. thomas.damato@jefferson.edu
Journal
J Thorac Cardiovasc Surg. 2007 Feb;133(2):352-63. Epub 2007 Jan 9.
Abstract URL
Click here to view abstract

85. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.

Author
Moscetti L; Nelli F; Felici A; Rinaldi M; De Santis S; D'Auria G; Mansueto G; Tonini G; Sperduti I; Pollera FC; Moscetti L; Nelli F; Felici A; Rinaldi M; De Santis S; D'Auria G; Mansueto G; Tonini G; Sperduti I; Pollera FC;
Institution
Department of Medical Oncology, Central Hospital of Belcolle, Viterbo, Italy.
Journal
Cancer. 2007 Jan 15;109(2):274-81.
Abstract URL
Click here to view abstract

86. Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxel.

Author
Ceribelli A; Pino MS; Gelibter AJ; Milella M; Cecere FL; Caterino M; Facciolo F; Mirri A; Cognetti F; Ceribelli A; Pino MS; Gelibter AJ; Milella M; Cecere FL; Caterino M; Facciolo F; Mirri A; Cognetti F;
Institution
Division of Medical Oncology "A," Regina Elena Cancer Institute, Rome, Italy. aceribelli@yahoo.com
Journal
Cancer. 2007 Feb 15;109(4):727-31.
Abstract URL
Click here to view abstract

87. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).

Author
Phernambucq EC; Biesma B; Smit EF; Paul MA; vd Tol A; Schramel FM; Bolhuis RJ; Postmus PE;
Institution
Department of Pulmonary Diseases, VU Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
Journal
Br J Cancer. 2006 Aug 21;95(4):470-4. Epub 2006 Aug 8.
Abstract URL
Click here to view abstract

88. A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.

Author
Socinski MA; Ivanova A; Bakri K; Wall J; Baggstrom MQ; Hensing TA; Mears A; Tynan M; Beaumont J; Peterman AH; Niell HB;
Institution
Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. socinski@med.unc.edu
Journal
Ann Oncol. 2006 Jan;17(1):104-9. Epub 2005 Oct 25.
Abstract URL
Click here to view abstract

89. Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe francais de pneumo-cancerologie).

Author
Thomas P; Robinet G; Gouva S; Fournel P; Lena H; Le Caer H; Perol M; Berard H; Bombaron P; Vergnenegre A; Kleisbauer JP;
Institution
Service d'Oncologie Respiratoire, Hopital Sainte-Marguerite, 270 Bd Sainte-Marguerite, 13009 Marseille, and Service de Pneumologie, Hopital Nord, Centre Hospitalier Universitaire de Saint-Etienne, France. pascal.thomas@ch-gap.fr
Journal
Lung Cancer. 2006 Jan;51(1):105-14. Epub 2005 Nov 28.
Abstract URL
Click here to view abstract

90. Multicenter phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small-cell lung cancer.

Author
Recchia F; Saggio G; Nuzzo A; Biondi E; Di Blasio A; Cesta A; Candeloro G; Alesse E; Rea S;
Institution
Unita Operativa di Oncologia, Ospedale Civile di Avezzano, Avezzano, Italy. frecchia1946@libero.it
Journal
J Immunother. 2006 Jan-Feb;29(1):87-94.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10 11 12